Brand Name Drugs News
Most Popular Brand Name Drugs Story
Drug marketing costs double R&D
Every self-respecting pharma exec will tell you: R&D is the industry's peculiar burden, the chief reason why brand-name drugs are so expensive. But the average Joe or Jane consumer thinks that's, Read more...
Latest Headlines
- December 12, 2011
- September 13, 2011
- September 9, 2011
- October 21, 2010
- August 11, 2009
- May 19, 2009
- December 3, 2008
- September 4, 2008
- April 11, 2008
- March 12, 2008
- March 5, 2008
- March 3, 2008
- January 25, 2008
- January 7, 2008
- January 4, 2008
- November 1, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
